Qiagen has announced that Tom Clement has joined the company as vice-president, regulatory approvals and clinical affairs.
Clement will direct and coordinate Qiagen's regulatory affairs department and all global activities related to regulatory submissions.
He joins Qiagen from Roche Molecular Systems, where he was vice-president of quality and regulatory.
